KALA BIO Disclosed Failure to Satisfy a Continued Listing Rule or Standard

The U.S. Air Force awarded Boeing a $131.23 billion contract for F-15 production, modernization, and sustainment through 2037. The contract includes options for foreign military sales to several countries. Initial funding is $343,740 for fiscal 2026. Boeing will perform the work in St. Louis. The contract does not guarantee full spending and includes no immediate jet orders.

Anfield Energy (TSXV, Nasdaq: AEC) plans to raise $50M to refurbish Utah's Shootaring Canyon mill, aiming for a 2028 reopening. The mill will process uranium and vanadium, reducing U.S. reliance on imports. Capital expenditures are estimated at $80.1M, with flexibility in financing options. The company expects a mill licence by late 2024 or early 2027, unlocking financing and construction. An updated PEA forecasts significant after-tax NPV and IRR, with production from Velvet-Wood and Slick Rock

Blackstone Inc. is selling up to 11.1 million units (25.03%) of its stake in Knowledge Realty Trust, valued at $1.25 billion. The sale, priced at a 4.7% discount, will reduce Blackstone's ownership to 21.5% if fully exercised, making Sattva Group the largest shareholder with 32%.

CF Industries, JERA, and Mitsui began constructing a $3.7B low-carbon ammonia plant in Louisiana, producing 1.4M tons annually. The plant will sequester 98% of CO₂ emissions, with CF Industries owning 40%. Ammonia will supply U.S. farmers and Asian power plants, creating 3,900 jobs during construction and 100 permanent roles. Production is expected to start in 2029, according to the companies.

Rivian (RIVN) fell 6% after CFO Claire McDonough resigned to join GE Vernova (GEV), which dropped 3%. Lucid (LCID) slipped 1%, while Tesla (TSLA) held steady. McDonough secured a $5.8B Volkswagen investment for Rivian. The S&P 500 (SPY) rose 0.48%, isolating EV sector weakness.

Moderna's stock dropped 6% after announcing a $2.6B private offering of convertible senior notes due 2032. The company aims to raise $2.56B, using proceeds for capped call transactions and general corporate purposes. Shares fell to $135.73, within a 52-week range of $22.28 to $176.66.